Protection against SHIV Challenge by Subcutaneous Administration of the Plant-Derived PGT121 Broadly Neutralizing Antibody in Macaques
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: 10.1371/journal.pone.0152760
- Event
-
Veröffentlichung
- (where)
-
Aachen
- (who)
-
Universitätsbibliothek der RWTH Aachen
- (when)
-
2016
- Creator
-
Rosenberg, Yvonne J.
Montefiori, David C.
LaBranche, Celia C.
Lewis, Mark G.
Sack, Markus
Lees, Jonathan P.
Jiang, Xiaoming
- DOI
-
10.18154/RWTH-2017-01257
- URN
-
urn:nbn:de:101:1-2018101606071772739113
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:48 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rosenberg, Yvonne J.
- Montefiori, David C.
- LaBranche, Celia C.
- Lewis, Mark G.
- Sack, Markus
- Lees, Jonathan P.
- Jiang, Xiaoming
- Universitätsbibliothek der RWTH Aachen
Time of origin
- 2016
Other Objects (12)
AAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing Activity
Identification of a novel broadly neutralizing antibody targeting HIV-1
Mechanisms of sterilizing immunity after passive immunization with an HIV neutralizing antibody
Restriction of hiv-1 escape by a highly broad and potent neutralizing antibody
Restriction of HIV-1 escape by a novel highly broad and potent neutralizing antibody
Intranasal administration of a monoclonal neutralizing antibody protects mice against SARS-CoV-2 infection
Structural Basis for the Recognition of Human Cytomegalovirus Glycoprotein B by a Neutralizing Human Antibody
A neutralizing IL-11 antibody reduces vessel hyperplasia in a mouse carotid artery wire injury model
Delta or Omicron BA.1/2-neutralizing antibody levels and T-cell reactivity after triple-vaccination or infection
Antibody technologies and protein engineering for the generation of novel antibody-derived entities with therapeutic potential
Neutralizing antibody formation with onabotulinumtoxinA (BOTOX®) treatment from global registration studies across multiple indications: a meta-analysis
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
AAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing Activity
Identification of a novel broadly neutralizing antibody targeting HIV-1
Mechanisms of sterilizing immunity after passive immunization with an HIV neutralizing antibody
Restriction of hiv-1 escape by a highly broad and potent neutralizing antibody
Restriction of HIV-1 escape by a novel highly broad and potent neutralizing antibody
Intranasal administration of a monoclonal neutralizing antibody protects mice against SARS-CoV-2 infection
Structural Basis for the Recognition of Human Cytomegalovirus Glycoprotein B by a Neutralizing Human Antibody
A neutralizing IL-11 antibody reduces vessel hyperplasia in a mouse carotid artery wire injury model
Delta or Omicron BA.1/2-neutralizing antibody levels and T-cell reactivity after triple-vaccination or infection
Antibody technologies and protein engineering for the generation of novel antibody-derived entities with therapeutic potential
Neutralizing antibody formation with onabotulinumtoxinA (BOTOX®) treatment from global registration studies across multiple indications: a meta-analysis
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
AAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing Activity
Identification of a novel broadly neutralizing antibody targeting HIV-1
Mechanisms of sterilizing immunity after passive immunization with an HIV neutralizing antibody
Restriction of hiv-1 escape by a highly broad and potent neutralizing antibody
Restriction of HIV-1 escape by a novel highly broad and potent neutralizing antibody
Intranasal administration of a monoclonal neutralizing antibody protects mice against SARS-CoV-2 infection
Structural Basis for the Recognition of Human Cytomegalovirus Glycoprotein B by a Neutralizing Human Antibody
A neutralizing IL-11 antibody reduces vessel hyperplasia in a mouse carotid artery wire injury model
Delta or Omicron BA.1/2-neutralizing antibody levels and T-cell reactivity after triple-vaccination or infection
Antibody technologies and protein engineering for the generation of novel antibody-derived entities with therapeutic potential
Neutralizing antibody formation with onabotulinumtoxinA (BOTOX®) treatment from global registration studies across multiple indications: a meta-analysis